Cann Group Limited
Australia-based Cann Group was one of the first pharmaceutical cannabis companies to be issued with a license by the Australian government. By using a vertically integrated business model, Cann Group plans to become industry leaders in medical cannabis manufacturing, production, cultivation, and breeding, thus enabling them to supply products aimed at a range of medical conditions.
Australia-based Cann Group was one of the first pharmaceutical cannabis companies to be issued with a license by the Australian government. By using a vertically integrated business model, Cann Group plans to become industry leaders in medical cannabis manufacturing, production, cultivation, and breeding, thus enabling them to supply products aimed at a range of medical conditions.
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
CAN |
$364,987
|
99.89% |
$0.6566
|
| CNGGF |
Total volume
$1,024
|
0.28% |
Stock price
$0.6451
|
